Table 1 Demographics and other characteristics of study subjects
From: Low immunoglobulin levels affect the course of COPD in hospitalized patients
Parameters | (N = 51) |
|---|---|
Age (years) (median {IQR}) | 67 (61.0–75.0) |
Sex—female (n {%}) | 26 (53%) |
BMI* (kg/m2) (median {IQR}) | 26.3 (20.2–32.9) |
Current smoking* (n {%}) | 12 (24.4%) |
Number of pack years* (median {IQR}) | 45.0 (24.1–52.5) |
FEV1** (% predicted) (median {IQR}) | 37.0 (22.5–49.9) |
FEV1/FVC** (%). (median {IQR}) | 42.5 (36.6–50.4) |
IgG (median {IQR}) | 8.27 (6.53–10.07) |
IgA (median {IQR}) | 1.97 (1.49–2.69) |
IgM (median {IQR}) | 0.91 (0.49–1.37) |
Subjects taking systemic corticosteroid (%) | 48 (82.8%) |
Subjects taking antibiotics (%) | 46 (79.3%) |